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Abstract 
 
Background: MicroRNAs are endogenous non-coding RNAs with important regulatory and cell fate functions. 
Many studies have shown that several microRNAs are obviously up-regulated during stem cell differentiation. 
The question rises here is weather inhibiting differentiation will affect the stemness and self renewal status of 
stem cells.  
 
Methods: miRCURY ™LNA microRNA inhibitor (anti-miR-145 and anti-let7g) are a sequence-specific and chem-
ically modified oligonucleotide that specifically target and knockdown miR-145 and let7g miRNA molecules. 
Unrestricted somatic stem cells (USSCs) were isolated from umbilical cord blood and treated with LNAs. The 
effect of anti-miRNA transfection was assessed by quantitative real-time PCR.  
 
Results: Real-time PCR showed that LNA was efficiently introduced into the cells and reduced miR145 and 
Let7g expression levels to 40% and 10% in relation to corresponding scramble control, respectively. Gene ex-
pression analysis as to self renewal and expansion showed more than 3.5 fold up regulation in Oct4 in cells 
treated with mir145 inhibition. Similarly a significant up to 2.5 fold up-regulation in Oct4 and cMyc expression was 
observed in samples treated with anti-let7g.  
 
Conclusion: Suppression in differentiation inducing microRNAs (miR-145 and let7g) can enhance the self re-
newal and stemness status of USSCs at transcriptional level. 
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Introduction 
 
Newly emerged key regulators of gene expression, 
better known as microRNAs are small non-coding 
RNAs with about 22 nucleotide length. These tiny 
elements function by inhibiting translation and pro-
tein synthesis. Recent studies have shown the power 
of microRNAs in cellular processes in all multicellu-
lar organisms including development, metabolism 
and ageing
1 specially in the regulatory circuitries that 
control self-renewal and pluripotency.
2 It has been 
shown that several microRNAs increase during dif-
ferentiation, suggesting a critical role in maintaining 
cell cycle and self-renewal.  
After the first generation of iPS,
3 many methods 
have been developed but the common, well defined 
protocol known as the “Yamanaka’s method” is per-
formed by overexpressing a set of speciﬁc genes 
(Oct4, Sox2 cMyc, Klf4) that are highly expressed in 
ESCs.
3,4 Thomson and coworkers produced iPS cells 
by transforming human somatic cells into pluripotent 
stem cells using Oct-3/4, Sox2, Nanog, and a differ-
ent gene, lin28, with a lentiviral system.
5 It has been 
suggested that apart from transcription factors and 
epigenetic modifications, microRNAs can also con-
tribute to cell reprogramming.
6,7  
It is interesting that the aforementioned repro-
gramming gene lin28 inhibits the biogenesis of the 
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let7 family of microRNAs,
8,9 which has a role in the 
propagation of breast cancer cells.
10 Therefore, lin28 
may actually promote reprogramming by the initia-
tion of differentiation induced by the let7g mi-
croRNA. Another miRNAs that have been detected to 
be of major importance and prevalence among adult 
cells is mir145 which has also been demonstrated to 
work against pluripotency, ie. initiating differentia-
tion. It has been shown that both of these elements 
increase during ESC differentiation.
11  
As mentioned, it has been shown that specific 
miRNAs regulate mammalian cellular differentiation 
and developmental patterning in a tissue specific 
fashion. One of the largest miRNA families is let-7 
which indicates such activities.
12-20 The well recog-
nized let-7 family is comprised of 12 family members 
located on 8 different chromosomes.
21-23 The sequen-
tial expression of let7 RNAs has shown to regulate 
and synchronize specific stages of development.
24,25 
A recent study has shown that lin28 inhibits an early 
transcript of let7g which is expressed in somatic cells. 
Let-7g levels have been demonstrated to be regulated 
by lin28, a protein highly expressed in pluripotent 
cells, by inhibiting the Dicer-mediated processing of 
pre-let-7 to mature let-7.
9,26 
It is worth mentioning that the promoters of both 
let-7 g and lin28 are occupied by the embryonic tran-
scription factors Oct4, Sox2, Nanog, and Tcf3 in mice 
suggesting that these factors promote the transcription 
of both primary let-7g and lin28, which then blocks 
the maturation of let-7 g.
27  
Kosik et al.
11 found that mirR-145 functions to regu-
late as well as modulate the differentiation progress in 
hESC differentiation through Oct4/Sox2 pathway. 
Identification and unique conservation of mir 145 
seed sequence in many species (mice,
22 human
28) and 
organs such as uterus, ovary, testis, prostate, spleen, 
muscle and heart
19,29 showed the evolutionary im-
portance and critical impact of this microRNA in cell 
fate.
30 In line with bioinformatic predictions; tar-
getScan,
31 miRBase
32 and Miranda,
33 it was demon-
strated that mir145 represses pluripotency and con-
trols ESC differentiation through interaction with 
three core pluripotency factors Oct4, Sox2, and 
Klf4.
11 Up-regulation of miR-145 expression caused a 
significant diminution of the self-renewal marker 
SSEA-4 and an increase in multiple differentiation 
markers associated with all three germ layers.
11 
A new adult stem cell isolated from umbilical cord 
blood, which has high propagation potential, low im-
munogenicity and easy isolation, are unrestricted so-
matic stem cells (USSCs). USSCs are a rare population 
of intrinsically pluripotent cells in human cord 
blood.
34,35 These cells do not express CD45, grow ad-
herently, and can be expanded without losing pluripo-
tency. These cells can homogeneously differentiate into 
osteoblasts, chondroblasts, adipocytes, hematopoietic, 
and neural cells, including astrocytes and neurons in 
vitro
35,36 and in vivo, also showed differentiation to mes-
odermal and endodermal pathways in animal models.
37 
Fallahi-Sichani et al.
38 reported that USSCs can be dif-
ferentiated in vitro into neuron-like cells expressing 
genes associated with development and/or survival of 
dopaminergic mesencephalic neurons. 
Although several studies have shown the im-
portance of microRNAs in cell fate and their effect on 
pluripotent genes, there is no study to examine the 
impact of inhibiting further differentiation in adult 
stem cells. Working with USSCs, we made a profile 
of the microRNAs that are expressed in these cells 
(data not published) which shows that both mir145 
and let7g are expressed in these cells. Considering the 
potential role of miRNAs in cell fate, in the present 
study, we applied miRCURY LNA™ miR-145 inhib-
itor (anti-miR-145) and let7g inhibitor (anti-let7g) to 
knockdown miR-145 and let7g molecules in unre-
stricted somatic stem cells, and evaluated the effect of 
these microRNAs on stemness. The anti-miRNA in-
hibitors are sequence-specific oligonucleotides that 
specifically target and knockdown miRNA molecules, 
and have been applied to investigate miRNA functions 
in several studies.
11,39,40 The results suggested that sup-
pression of miR-145 can induce favourable gene ex-
pression in the self renewal pathway but not strong 
enough to make a considerable difference. 
 
 
Materials and Methods 
 
USSC isolation was performed by collecting human 
umbilical cord blood with informed consent of the 
mother according to kogler et al. protocol.
35 The mon-
onuclear cell fraction was isolated by Ficoll (Bio-
chrom) gradient separation accompanied with subse-
quent lysis of RBCs by ammonium chloride. An aver-
age portion of 6–7_10
6 cells/ml was plated in T25 cul-
ture flasks (Costar). For initial growth of the adherent 
USSC colonies, two different medias were employed 
including myelocult medium (Stem Cell Technologies) 
and low glucose DMEM (Cambrex) with 30% FCS, 
dexamethasone (10_7 M; Sigma-Aldrich), penicillin 
(100 U/ml;Grünenthal), streptomycin (0.1 mg/ml; Jamshidi Adegani et al. 
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Hefa-pharma), and ultraglutamine (2 mM; Cambrex). 
After isolation, USSCs were expanded in high 
DMEM medium, supplemented with 10% FBS.
34,35,38 
USSCs were transfected with 50 nM of miRCU-
RY LNA™ (Exiqon) targeting each miRNA using 
lipofectamin 2000
® (Invitrogen). Twnty four hours 
prior to transfection, 2×10
4cells were plated into 12-
well plates to acquire 50% cell density at the time of 
transfection. The oligomer-lipofectamine™ 2000 
complexes were prepared as mentioned in the manu-
facturer protocol using Opti-MEM as diluents. Sam-
ples were harvested at three time points including 
days 2, 3 and 12 after transfection. To obtain maxi-
mum knockdown, two additional booster treatments 
were applied at day 3 and 5 after the first transfection. 
Knocking-down miR-145 and let7g was   
performed with anti-sense LNA oligomers. miRCU-
RY LNA knockdown probes target sequence for miR-
145 (miRCURY knockdown 412385-00), is 5’-
GGATTCCTGGGAAAACTGGA-3’, for miR- let7-g 
(miRCURY knockdown 410026-00) is 5’-
ACTGTACAAACTACTACCTC-3’, and for scram-
ble miRNA (miRCURY knockdown, 19900204 
scramble-miR) LNA probes as negative control, were 
purchased from EXIQON, Inc. The same protocol for 
siRNA transfection was performed to tansfect LNA 
probes into cells using lipofectamine™ 2000 as de-
scribed above. 
The repression of miRNAs was assessed both 48h 
and 12 days after the first transfection. miRNA ex-
traction of samples was carried out by our modified 
total RNA isolation with QIAzol lysis reagent. The 
RNA concentration was quantified using an Eppen-
dorf AG biophotometer (Eppendorf).  
The detection of miRNAs was performed with 1st-
strand cDNA synthesis kit (Agilent Technologies, 
Stratagene Products Division) which provides the 
reagents to elongate miRNAs in a polyadenylation 
reaction and then reverse transcribe the polyadenylat-
ed RNA into QPCR-ready cDNA. The cDNA may 
then be amplified using the provided universal re-
verse primer and a unique forward primer that is spe-
cific to the miRNA target of interest. Respectively, 
the primer sequence for miR145 is 5’- GTCCAG-
TTTTCCCAGGAATCC -3’ and for let7g is 5-
TGAGGTAGTAGTTTGTACAGTT-3’. Forward 
primer of U6–snoRNA (5’- AAATTGGAACGATA-
CAGAGAAG -3’) was used as the endogenous con-
trol. The extended protocols are provided online by 
the manufacturer. Briefly, reverse transcription of 1 
μg total RNA by the 1st-strand cDNA synthesis kit 
(Agilent Technologies) was followed by 45 cycles of 
realtime PCR using the miRNA QPCR master mix 
(Agilent Technologies, Stratagene Products Divi-
sion). miRNA levels were normalized against the 
snoRNA control. 
The polyadenylation reactions are prepared by 
adding 4 μl of 5× poly A polymerase buffer 1 μl of 
rATP (10 mM), required appropriate amount of RNA 
(1 μg ) with RNase-free water to bring to a final vol-
ume of 20 μl. Addition of 1 μl of E. coli poly A pol-
ymerase to each reaction fallowed by 30 minutes of 
incubation at 37°C 
A further 5 minutes at 95°C to terminate adenyla-
tion and immediate transfer to ice which is essential 
at this step.1st-strand cDNA synthesis is the subse-
quent reaction prepared by adding the following 
components: 2 μl of 10× affinity script RT buffer, 4 
μl of the polyadenylation reaction in the last step, 0.8 
μl of dNTP mix (100 mM), 1 μl of RT adaptor primer 
(10 μM) and 1 μl of affinity script RT/RNase block 
enzyme mixture. Incubate the reactions at 55°C for 5 
minutes, followed by 15 minute incubation at 25°C 
and subsequent 42°C for 30 minutes to allow reverse 
transcription of 1st-strand cDNA and finally, 5 
minutes at 95°C to terminate the reverse transcription. 
To screen specific amplification, a no-PAP  control 
cDNA was prepared from a polyadenylation reaction 
in which the poly A polymerase was omitted. Quanti-
tative Real time PCR reaction was carried out accord-
ing to manufacturer instructions using a unique for-
ward primer and a universal primer provided in the 
kit as the reverse primer in the amplification process. 
For RT-PCR analysis, total cellular RNA was ex-
tracted using QIAzol-reagent (Qiagen). Synthesis of 
cDNA was carried out with MMuLV reverse tran-
scriptase and random hexamer, according to the man-
ufacturer’s instructions (Fermentas). Primers used for 
qPCR were shown in supplementary Table 1. The 
GAPDH transcripts were used as internal control. 
PCR amplification was performed using Maxi-
ma™SYBR green/fluorescein qPCR Master mix 
(Fermentas) with a two step procedure of an initial 
denaturation at 95°C for 10 minutes, followed by cy-
cles circulating 15 seconds of 95°C and 60 seconds of 
annealing/extension at 60°C. The number of cycles 
varied between 30 and 40, depending on the abun-
dance of particular mRNA. The primers and product 
lengths were listed in supplementary Table 1. All re-
actions were performed in triplicates and normalized 
to the internal control gene. Changes in microRNA 
and mRNA expressions were normalized to the   MicroRNAs affect stemness of USSCs 
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relevant internal control, and subsequently calculated 
using the 2
-ΔΔCt method. The rotor gene 6000 detec-
tion system (Corbett) was used for quantitative miR-
NA and mRNA transcript expressions. 
 
 
Results 
 
The transfection efficiency of the LNAs was exam-
ined using a negative control (miRCURY knockdown 
scramble-miR, 199002-04) 24 hours after transfec-
tion. The same protocol for transfection of siRNAs 
using the lipofectamine 2000® reagent was applied. 
The efficiency was calculated by counting ten fields 
of view and taking into account the ratio of fluores-
cent cells (signals omitted from FITC conjugated 
LNA) to all the cells countable in each view. Working 
with lipofectamine™ 2000 reagent showed a minimum 
of 70% transfection ratio. This shows that the majority 
of USSCs have possessed the LNA for maximum 
knock down of target miRNA. These cells were then 
used as negative controls for relative quantification. 
Real-time PCR analysis revealed that anti-miR-
145 transfection significantly reduced miR-145 levels 
to 40% in USSCs compared to negative scramble 
control (Figure 1), confirming that anti-miR-145 was 
efficiently introduced into the cells and knocked 
down miR-145. Also USSCs was transfected with 
anti- let7 g, and showed that the let7 g levels reduced 
to 10% and the expression levels persisted until day 
12 (Figure2). 
Expression levels of the indicated miR 145 and 
let7 g with corresponding anti-miR treatments was 
demonstrated after 12 days of transfections. The miR-
scramble was the no-target control which had no tar-
gets. USSCs were transfected with miRCURY LNA 
knockdown probes against the named hsa-mir targets 
and the inhibition was analyzed relative to an internal 
RNA control, the sno-RNA U6. Each experiment was 
performed in duplicates, accompanied with a repre-
sentative control. Statistical significance of the results 
were assessed using student t-test (*p<0.05).  
To assess the effect of treatments with LNA com-
pounds, target genes which our microRNAs regulated 
were examined with quantitative real time PCR. As 
mentioned, Oct4, Klf4, cMyc and Sox2 were the   
Table 1: The primers and product lengths (Supplementary).
Gene  Forward  Reverse Product size (bp)
Oct4   CGC CGT ATG AGT TCT GTG  GGT GAT CCT CTT CTG CTT C  284 
Sox2  GGA CTG AGA GAA AGA AGA GGA G  GAA AAT CAG GCG AAG AAT AAT  196 
cMyc  AGC GAC TCT GAG GAG GAA C  CTG CGT AGT TGT GCT GAT G  183 
Lin28  AAA GGA GAC AGG TGC TAC  ATA TGG CTG ATG CTC TGG  107 
GAPDH  CTC TCT GCT CCT CCT GTT CG  ACG ACC AAA TCC GTT GAC TC  113 
 
 
Fig. 1: Gene expression after knockdown of mir145. 
*Jamshidi Adegani et al. 
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direct targets for mir145. Likewise, the target for let7 
g was shown to be lin28. After transfection, the cells 
were harvested and analyzed for gene expression in 3 
time points. Samples were collected 48 and 72 hours 
after transfection accompanied with a final analysis at 
day 12. To gain maximum knockdown, booster 
treatments were applied in two time points, days 3 
and 5. Samples of each time point were analyzed with 
corresponding controls. 
Expression of mir145 was reduced by 60% (Figure 1) 
versus corresponding control and it persisted for 12 
days after transfection of USSCs with targeted LNA 
compounds. At 48 and 72 hours after the transfection, 
levels of target gene expression were compared to the 
negative scramble control and the final microRNA 
and target genes were examined 12 days after the first 
transfection. 
An approximately 3.6 fold up regulation in ex-
pression of Oct4 was detected in response to down-
regulation of mir145 (Figure 1). The significant and 
gradual upregulation of Oct4 initiated 72 hours after 
the transfection and continued to day 12 where the 
highest expression was detected.  
Also, anti-miR145 treated cells were analyzed for 
other target genes including cMYc, Sox2 and Klf4 
with qRT-PCR analysis. cMyc expression also 
showed an up-reguation approach in response to the 
treatment, but the changes were not as significant as 
Oct4 expressions. It is worth noting that it appears 
that cMyc expression was altered with each booster 
treatments and the up-regulation was a direct effect of 
miR145 repression but the up-regulation did not per-
sist to make a significant difference. qRT-PCR analy-
sis of Sox2 and Klf4 expression did not amplify any 
products, correlating with controls. 
Considering the effect of lin28 in let7 g expression 
and the indirect effect of the gene in differentiation, 
we assessed the existence of the gene in anti-mir145 
treated cells. The results showed a 45% decrease in 
lin28 for treated USSCs. Regarding that, after 12 days 
of treatment the expression level of mir145 had de-
creased to 60% but the level of let7 g showed an in-
crease during this time (data not shown). At 48 hours 
post-transfection, expression of target and internal 
control genes were analyzed by RT-qPCR. Expres-
sion of target genes was normalized to GAPDH and is 
presented as the fold change in expression relative to 
miR-scramble treatment.  
USSCs were transfected with miRCURY LNA 
knockdown probes against the named hsa-mir targets 
and the inhibition was analyzed relative to an internal 
RNA control, the sno-RNA U6. Expression levels were 
measured using quantitative real time PCR and the 
miRNA QPCR master mix. Each experiment was per-
formed at least two times, in duplicates, accompanied 
with a representative control. * Statistically significant 
alterations in gene expression were compared to the cor-
responding controls. Statistical significance of the re-
sults were assessed using one way Anova (*p<0.05).  
Targeting let7 g in USSCs, expression of let7 g 
was reduced by 90%, versus corresponding controls 
at day 12 (Figure 3). Although the only known target 
of let7 g was lin28 gene, we also examined the ex-
pression of four other pluripotent markers for any 
 
 
Fig. 2: Knockdown of microRNAs by LNA knockdown probes targeting mir145 and let7 g. 
*
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changes induced by let7 g knock down. The direct 
effect of let7 g inhibition was notably the up-
regulation of lin28 within 72 h of transfection. The 
changes detected after induction was the expression 
of Oct4, cMyc on day 12. With approximately 2.5 
fold upregulation in both Oct4 and cMyc, significant 
up-regulation could only be observed 12 days after 
transfection. The surprising fact that, regarding the 
over expression of lin28 after instant knockdown of 
let7 g, it seems that it could not be maintained until 
day 12, considering the booster treatments. The ex-
pression levels of Sox2 and Klf4 were again not de-
termined due to an absence in amplification. Inhibi-
tion of let7 g expression in USSCs by specific se-
quence specific anti-miR was determined by RT-
qPCR analysis. Transfection of anti-let7 g and scram-
ble Ccontrol were also carried out using lipofec-
tamine 2000 reagent.  
qRT-PCR analysis of let7 g-inhibited USSCs and 
the corresponding scramble control. The expression 
levels of Oct4, c-Myc and lin28 were obviously dif-
ferent, where in the case of pluripotent genes Oct4, 
and cMyc up-regulation relative to the control was 
observed. The expression levels were normalized to 
GAPDH gene and are presented as the fold change in 
expression relative to no treatment. * Statistically 
significant alterations in gene expression were com-
pared with the corresponding controls. Statistical sig-
nificance of the results were assessed using one way 
Anova (*p<0.05).  
 
 
Discussion 
 
We were interested in investigating the effect of mi-
croRNAs in stem cell fate and self-renewal. The cel-
lular response to crucial microRNAs is of particular 
importance, especially when the fate of pluripotent 
genes has shown to be regulated by these minuscule 
elements.
1,24,41,42 In this study, we looked upon the 
effect of certain microRNAs on self-renewal factors 
such as Oct4, Sox2, Klf4, cMyc and lin28 which play 
an essential role in stem cell maintenance and propa-
gation.
1,8,10,11,43 Treating our target cell, USSCs, with 
anti-sense oligonucleotids caused a considerable sup-
pression in microRNA expression, where let7 g and 
mir145 reduced to 10% and 40% relative to scramble 
control, respectively. 
Considering that microRNAs function by reducing 
the expression level of their targets, we would expect 
an increase in target gene expression. During treat-
ment of USSCs with anti-miR145, target genes (Oct4, 
Sox2, Klf4) were examined for changes. At this level, 
Oct4 expression was the only significant change no-
ticed after treatment. Oct4 showed a significant up-
regulation throughout the treatment period. This is 
 
 
Fig. 3: Gene expression changes in let7 g-inhibited USSCs. Jamshidi Adegani et al. 
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relevant to previous studies which indicate the role of 
mir145 in Oct4 expression.
11 But the fact that other 
targets including Sox2 and Klf4 did not change dur-
ing the treatment makes a controversial situation. 
After 48 hours of transfection, USSCs treated with 
anti-mir145, showed an up-regulation in cMyc, 
where as the expression of other defined targets 
(Oct4, Sox2, Klf4) showed no changes. But examin-
ing the results of gene expression 72 hours after 
transfection revealed that the level of cMyc expres-
sion reduced to half, which suggests that in addition 
to miR145, there are other regulators for cMyc 
which act to maintain the level of cMyc transcript. 
In addition, cMyc continued to be regulated despite 
the reduction observed in miR145 after 12 days of 
treatment. Although this change in gene expression 
was not statistically significant, but the pattern pro-
duced confirms that adjacent to microRNAs, other 
regulatory systems are involved.
44-46  
Although the insignificant change in cMyc expres-
sion was suggested to be contributed to the im-
portance of the regulatory role of cMyc in the cell 
cycle, and also the oncogenic potential of this fac-
tor
,47,48 the unrestrained expression of this gene could 
result in totally different scenario for stem cell fate.  
In the case with anti-let7 g treated USSCs, the re-
sults indicate that the target gene, Lin28 is considera-
bly up-regulated after 72 hours of transfection. Alt-
hough this shows a direct effect of let7 g on lin28,
8,49 
but this does not persist until the end of the trial. At 
day 12, lin28 expression reduces in comparison to 
relevant controls, producing the same effect observed 
in the parallel experiments with anti-miR145. As ob-
served in both occasions, it seems that the target 
genes resist the inhibition induced through anti-sense 
transfections. Considering that both cMyc and lin28 
play a crucial role in the cell cycle, perhaps the op-
posing act observed to resist the up-regulation of es-
sential factors considered for self-renewal, it is regu-
lated accurately that maintenance in gene expressions 
are decisive to cell fate.
30 As seen, the controversial 
fate of a cell is presumed to be “fine tuned” rather act 
directly in the circuitry involved for preserving the 
stem cell status. It is interesting that the complex 
network controlling self-renewal also inhibits factors 
contributing to uncontrolled cell propagation.
18,50  
Although lin28 up regulation does not persist but 
the results signify another observation, where the ex-
pression of Oct4 and cMyc seems to up regulate to 
approximately 2.5 fold compared with untreated con-
trols. The transition in gene expression is probably an 
indirect effect of transient lin28 up-regulation or other 
affecting sources. As seen with anti-mir145 treated 
cells, Sox2 and Klf4 expression did not change due to 
anti-let7 g treatment. Perhaps the elements acting up-
on these factors are either not targeted by let7 g and 
the indirect effect observed with cMyc and Oct4 is 
considered irrelevant. 
All together, the indirect and direct effects ob-
served in this studies point to the potentials of mi-
croRNAs in stemness of somatic stem cells. Although 
the act of one microRNA may not be adequate to 
change the fate of stem cell, but it has the potential to 
manipulate the accurate regulation of pluripotency 
network. Stemness is often considered by significant 
expression of pluripotent genes such as Oct4, Nanog, 
Sox2, … but to define the exact criteria as to stem-
ness is controversial.
51 
Working towards better understanding of the pro-
cess controlling the “stemness” of stem cells, it is 
crucial to select a reliable and high standard source of 
stem cell for examination. In this study, considering 
the ease of isolation, low immunogenicity and high 
propagation potential, made USSCs the desired cells 
for examination. Taking into account that USSCs are 
pluripotential stem cells isolated from umbilical cord 
blood, which was shown to be an abundant resource 
for a verity of stem cells, and accessible through cord 
blood banks, the aforementioned criteria make 
USSCs a valuable candidate for therapeutic purposes. 
Considering that the source of somatic stem cell is an 
essential factor in cell based therapies, it is best to 
work on available resources such as cord blood banks 
which are expanding by day. 
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